Parkinsonian DisordersParkinson Disease, SecondaryParkinson DiseaseParkinson Disease, PostencephaliticLevodopaDihydroxyphenylalanineAntiparkinson AgentsGuadeloupe1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDyskinesia, Drug-InducedSupranuclear Palsy, ProgressiveHypokinesiaDystoniaMultiple System AtrophyDyskinesiasSubstantia NigraTremorMPTP PoisoningCarbidopaMuscle RigidityGlobus PallidusMovement DisordersTrihexyphenidylLewy Body DiseaseLewy Bodiestau ProteinsDopamineTauopathiesCycasOxidopamineUbiquitin-Protein LigasesCorpus Striatumalpha-SynucleinManganese PoisoningBenserazideBrainMMPIOlivopontocerebellar AtrophiesDopamine AgentsBasal Ganglia DiseasesDementiaBasal GangliaTropanesNeurologic ExaminationMutationMyelinolysis, Central PontineGlucosylceramidaseNerve DegenerationAnnonaceaePutamenAge of OnsetDystonic DisordersDopaminergic NeuronsTetrabenazinePedigreeSynucleinsExtrapyramidal TractsTyrosine 3-MonooxygenaseDopamine Plasma Membrane Transport ProteinsDysarthriaMucunaMagnetic Resonance ImagingHallucinationsChromosomes, Human, Pair 17SynkinesisDisease Models, AnimalREM Sleep Behavior DisorderAntipsychotic AgentsOlfaction DisordersChoreaNeuronsFrontotemporal DementiaSculptureGaucher DiseaseTime FactorsWeldingAtaxiaPick Disease of the BrainGenes, RecessiveHypotension, OrthostaticCerebellar AtaxiaDopamine AgonistsOrphenadrineHomovanillic AcidBromocriptineTranquilizing AgentsNeurodegenerative DiseasesSubthalamic NucleusStereotaxic TechniquesMotor ActivityNeurotoxinsMesencephalonDNA Mutational AnalysisAmantadine1-Methyl-4-phenylpyridiniumApomorphinePrimary DysautonomiasTomography, Emission-Computed, Single-PhotonAnticipation, GeneticLigases